ADHD and Anxiety Together: Which to Treat First

When ADHD and an anxiety disorder occur together, most clinicians treat whichever condition is more severe, more impairing or less stable first, then reassess the other once the first has improved. In practice that often means treating ADHD first when anxiety is mild and grows out of chronic disorganization, and treating anxiety first when panic, constant worry or avoidance is the bigger barrier to daily life.

Two findings make the decision less fraught than many people expect. Stimulants, on average, do not worsen anxiety in children with ADHD, and UK guidance says people with ADHD and an anxiety disorder should be offered the same ADHD medication choices as anyone else, with slower dose changes and closer monitoring. The sequence is a clinical judgment you make with your prescriber, not a fixed rule.

Why ADHD and anxiety are so often tangled together

ADHD rarely travels alone. In the national survey that produced the best-known estimate of adult ADHD in the United States, adult ADHD was highly comorbid with many other psychiatric disorders, and most adults with ADHD were untreated for it even though many had received treatment for those other conditions. That pattern matters here: an adult can spend years in care for "anxiety" while the attention problem underneath is never named.

The overlap runs in both directions. Chronic lateness, missed deadlines and forgotten commitments create real, repeated consequences, and anticipating those consequences feels like worry. Meanwhile, anxiety itself pulls attention toward threat and away from the task, which can look like distractibility on a checklist. Pediatric guidance reflects this: the American Academy of Pediatrics tells clinicians evaluating a child or teen for ADHD to at least screen for coexisting conditions, naming anxiety and depression among them.

The site's longer post on conditions that mimic or mask ADHD covers the look-alikes in detail. The short version: the question is rarely "ADHD or anxiety?" but "how much of each, and which is driving the other right now?"

Telling the two apart: what a careful evaluation looks for

No single questionnaire separates ADHD from anxiety. Rating scales help quantify symptoms, but an evaluator mainly looks at timing, content and context. The table below shows the distinctions clinicians usually explore.

Collateral history from someone who knew you as a child, old report cards and a timeline of when symptoms began carry a lot of weight. Medical contributors also deserve a look before either label is settled: sleep disorders, thyroid problems, heavy caffeine use and some medications can produce both inattention and anxiety. The guide to medical conditions to rule out before a psychiatric diagnosis lists the common ones, and ADHD rating scales explains what the questionnaires can and cannot tell you.

How clinicians decide which to treat first

A 2025 review of adult ADHD with anxiety and depression summarizes the guideline consensus this way: prioritize the most severe, functionally impairing and unstable condition, then address the others in sequence once it has stabilized or improved. Severity and stability usually matter more than which diagnosis came first.

Signs that anxiety should usually come first

• Panic attacks, agoraphobia or avoidance that keeps you from work, school or leaving home.
• Anxiety so constant that you cannot sit through an evaluation task or a medication trial without distress.
• Obsessive-compulsive symptoms, trauma symptoms or severe insomnia that dominate the picture.
• Uncertainty about whether attention problems would remain once worry is treated.

Signs that ADHD may reasonably come first

• A clear childhood history of inattention or hyperactivity that predates the anxiety.
• Worry that is mostly about real consequences of disorganization: late bills, missed deadlines, conflict at home.
• Anxiety that is mild to moderate and not producing panic or avoidance.
• Earlier anxiety treatment that helped worry but left focus and follow-through unchanged.

Some people need both addressed at once, for example with an ADHD medication plus cognitive behavioral therapy that targets worry. Others start with a treatment that can touch both conditions. Either way, write down the two or three outcomes that matter most to you before you start, so you and your prescriber can tell whether the first step worked.

Do stimulants make anxiety worse? What the evidence shows

Anxiety is listed among the most common adverse reactions in the prescribing information for lisdexamfetamine (Vyvanse), so the concern is real for some individuals. On average, though, the picture is different. A meta-analysis of 23 double-blind, placebo-controlled trials in 2,959 children with ADHD found that anxiety was reported less often with stimulants than with placebo (relative risk 0.86), and higher doses were associated with lower measured anxiety risk. The authors suggested that improved ADHD control may ease anxiety for many children, while acknowledging that some children do feel more anxious on a stimulant.

Longer-term observational data point the same way, with an important caveat. In a 10-year follow-up of boys with ADHD, those who had been treated with stimulants were significantly less likely to develop later depressive and anxiety disorders than those who had not. Because that study was not randomized, it shows an association, not proof that stimulants prevent anxiety.

What the evidence does not show: it does not tell you whether you personally will feel calmer or more on edge, and most of the trial data come from children rather than adults with an established anxiety disorder. That is why prescribers usually start low, change doses slowly and ask specifically about anxiety at each visit. UK guidance builds that in, advising slower titration and more frequent monitoring when ADHD coexists with an anxiety disorder. The site's post on starting ADHD medication at a low dose describes that approach.

Non-stimulant options when anxiety is prominent

Non-stimulants are not automatically better for anxious patients, but they are often discussed when anxiety is significant, when stimulant side effects were a problem, or when someone prefers to avoid a controlled substance. The comparison of stimulant and non-stimulant ADHD medication covers the classes in depth; the points below focus on anxiety.

The atomoxetine trials are encouraging but limited: they lasted 12 and 14 weeks and did not compare atomoxetine head to head with a stimulant in anxious patients. The guide to Qelbree and Strattera compares the two norepinephrine-based options.

Where anxiety medicines fit

When an anxiety disorder needs its own medication, a selective serotonin reuptake inhibitor is a common choice. Escitalopram (Lexapro), for example, is FDA-approved for generalized anxiety disorder in adults and children 7 and older, and like all antidepressants it carries a Boxed Warning about suicidal thoughts and behaviors in children, adolescents and young adults. An SSRI does not treat core ADHD symptoms, so people with both conditions sometimes take an SSRI and an ADHD medication together under one prescriber's supervision. The overview of anxiety treatment options compares SSRIs, buspirone and other choices.

CBT that addresses both conditions

Psychotherapy is not a fallback here; for many people it is half the plan. In a randomized trial of adults whose ADHD symptoms persisted despite medication, cognitive behavioral therapy produced greater symptom improvement than relaxation training with educational support, and responders kept their gains at 12 months. UK guidance suggests considering non-drug treatment for adults with ADHD who choose not to take medication, cannot tolerate it or still have significant impairment on it, and says that treatment may involve elements of, or a full course of, CBT.

CBT for ADHD and CBT for anxiety use overlapping tools aimed at different targets:

• ADHD-focused CBT builds external systems: calendars, task breakdown, reminders, and strategies for procrastination and time blindness.
• Anxiety-focused CBT works on worry patterns, avoidance and gradual exposure to feared situations.
• Combined work often starts with organization skills, because fewer dropped balls means fewer real reasons to worry, then moves to the worry that remains.

Coaching can help with daily structure, but it is not treatment for an anxiety disorder. The article on ADHD coaching versus therapy explains where the line falls.

Situations that change the plan

A few circumstances shift the usual reasoning, and they are worth raising early with your clinician.

• Children and teens. Parents and teachers often see different things: a child may look inattentive in class and anxious at home. Information from both settings, plus a plan that includes behavioral and school supports, usually matters as much as the medication decision. The guide to child anxiety treatment covers parent-led and CBT programs.
• Hormonal transitions. Some women notice that both focus and anxiety worsen premenstrually or in perimenopause. Tracking symptoms across the cycle can show whether timing, not a new diagnosis, explains the change; the article on perimenopause anxiety explains the options.
• Alcohol, cannabis and caffeine. People with ADHD and anxiety sometimes self-treat restlessness with alcohol or cannabis, or push through fatigue with large amounts of caffeine. Each can worsen sleep, anxiety and attention, and each changes how a prescriber weighs medication risks, so honest reporting helps you get a safer plan.
• Insomnia. Poor sleep magnifies both conditions. If you cannot fall asleep because of worry, or because your mind will not slow down at night, sleep may need its own treatment before either diagnosis can be judged fairly.

A worked example

Consider a hypothetical adult, an illustration rather than a real patient: a project manager who has always been "the scattered one," with report cards noting daydreaming. Since a recent promotion, she feels constant dread about missed details and lies awake reviewing her to-do list.

• The evaluation finds lifelong inattention that predates the anxiety, and worry mostly about consequences of disorganization. No panic attacks, no avoidance of leaving home.
• She and her prescriber agree to start with ADHD treatment plus CBT for organization skills, tracking both a focus measure and a weekly anxiety rating.
• At follow-up, focus has improved and the worry about work has eased, but she still lies awake. They address sleep and residual worry next rather than raising the ADHD dose.

Change one detail, such as weekly panic attacks or a recent trauma, and the same evaluator might reasonably treat the anxiety first. That flexibility is the point.

Questions to ask your clinician

• Based on my history, which condition do you think is driving the other right now?
• What would we track to know whether the first step is working, and when will we check?
• If a stimulant makes me feel more anxious, what is the plan: lower dose, different formulation or a non-stimulant?
• Should therapy start at the same time as medication, or after?
• Are there medical contributors, such as sleep, thyroid or caffeine, we should rule out first?
• Who coordinates if I see a separate therapist and prescriber?

Do not start, stop or change an ADHD or anxiety medication on your own; bring side effects to your prescriber, who can adjust the plan safely. If anxiety comes with low mood or thoughts of self-harm, read the companion guide on ADHD and depression together, which explains why mood safety comes first. If you are thinking about suicide or are in crisis, call or text 988 (the 988 Suicide & Crisis Lifeline) or go to the nearest emergency room.

How Dr. Lewis's practice approaches ADHD with anxiety

The practice's ADHD assessment is available for children and adults, in person or by telehealth, and combines a structured clinical interview, standardized rating scales that support but do not replace clinical diagnosis, and collateral history from a family member or close person. Treatment plans may include lifestyle changes, nutrition, psychotherapy, executive-function coaching and medication when appropriate, and the team's psychotherapists offer CBT among other approaches. A free discovery call is the place to ask whether that combination fits your situation. The guide hub on choosing psychiatric care and the overview of adult ADHD treatment options are good next reads.

Frequently asked questions

Can a stimulant cause an anxiety disorder?

Anxiety is a recognized side effect for some people, but trial data in children show anxiety reported less often on stimulants than on placebo overall. If anxiety rises after starting a stimulant, tell your prescriber; options include adjusting the dose or formulation, or switching classes.

Should I stop my SSRI before an ADHD evaluation?

No. Do not stop any medication on your own to prepare for an evaluation. Tell the evaluator what you take and when you started it; they can account for it, and stopping some antidepressants abruptly can cause discontinuation symptoms.

Is it possible that treating anxiety will make my ADHD symptoms disappear?

Sometimes attention improves a lot once worry is treated, which suggests anxiety was the main driver. If inattention dates back to childhood and persists when you are calm, it is more likely that ADHD is also present and will need its own plan.

Are benzodiazepines used for anxiety in people with ADHD?

They are generally used cautiously, if at all, for ongoing anxiety, because of sedation, dependence and effects on attention. Your prescriber can explain the alternatives covered in the anxiety treatment comparison.

Can a child with ADHD and anxiety take a stimulant?

Yes, in many cases. UK guidance offers the same ADHD medication choices when an anxiety disorder coexists; prescribers usually start low, adjust slowly and monitor anxiety closely, alongside behavioral or CBT-based support.

How long should a first step run before deciding it is not working?

It depends on the treatment. Stimulant effects show within days of each dose change, while non-stimulants, SSRIs and CBT take weeks. Agree on a review date and the outcomes you will track before you start.

Sources

1. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. American Academy of Pediatrics, Pediatrics 144(4):e20192528, 2019. pmc.ncbi.nlm.nih.gov
2. Attention deficit hyperactivity disorder: diagnosis and management (NG87), Recommendations. National Institute for Health and Care Excellence (NICE), 2018, updated 2019. nice.org.uk
3. Meta-Analysis: Reduced Risk of Anxiety with Psychostimulant Treatment in Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology 25(8):611-7 (Coughlin et al.), 2015. pubmed.ncbi.nlm.nih.gov
4. Vyvanse (lisdexamfetamine dimesylate) prescribing information. Takeda Pharmaceuticals / DailyMed (NLM), 2026. dailymed.nlm.nih.gov
5. Strattera (atomoxetine) prescribing information. Eli Lilly and Company / DailyMed (NLM), 2026. dailymed.nlm.nih.gov
6. Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder. Journal of the American Academy of Child and Adolescent Psychiatry 46(9):1119-1127 (Geller et al.), 2007. pubmed.ncbi.nlm.nih.gov
7. Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder. Depression and Anxiety 26(3):212-21 (Adler et al.), 2009. pubmed.ncbi.nlm.nih.gov
8. Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. JAMA 304(8):875-80 (Safren et al.), 2010. pubmed.ncbi.nlm.nih.gov
9. Lexapro (escitalopram) prescribing information. Allergan / DailyMed (NLM), 2026. dailymed.nlm.nih.gov
10. Adult ADHD and comorbid anxiety and depressive disorders: a review of etiology and treatment. Frontiers in Psychiatry (Fu et al.), doi:10.3389/fpsyt.2025.1597559, 2025. pmc.ncbi.nlm.nih.gov
11. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. American Journal of Psychiatry 163(4):716-23 (Kessler et al.), 2006. pubmed.ncbi.nlm.nih.gov
12. Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study. Pediatrics 124(1):71-8 (Biederman et al.), 2009. pubmed.ncbi.nlm.nih.gov
13. Intuniv (guanfacine extended-release) prescribing information. Takeda Pharmaceuticals / DailyMed (NLM), 2025. dailymed.nlm.nih.gov
14. Qelbree (viloxazine extended-release) prescribing information. Supernus Pharmaceuticals / DailyMed (NLM), 2026. dailymed.nlm.nih.gov

Educational information, not medical, tax or legal advice. Decisions about diagnosis, medication and treatment belong with a clinician who knows your history.